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background:  Multivessel (MV) coronary artery disease (CAD) is associated with worse outcomes than single vessel (SV) CAD in the 
setting of acute ST-segment elevation myocardial infarction (STEMI). Staged-PCI has recently been proposed as a treatment strategy in 
this setting. Data on the utilization and outcomes of this strategy are relatively unknown. 
methods:  Alladult (age ≥18 years) STEMI patients treated with staged PCI were identified from the National Inpatient Sample (NIS) for 
years 2003-2011 using ICD 9 codes. Baseline demographics, clinical characteristics and outcomes were analyzed. Patients with STEMI 
and MV CAD treated with staged PCI were compared with a broad group of STEMI patients treated with culprit only (CO) PCI. 
Results: 8180 (1.3%) staged PCIs for MVD were performed out of 62,923 total PCIs for STEMI. Patients treated with staged PCI were 
older (61.95-vs-61.01 years, p<0.001) and more likely to be men (74.3%-vs-70.9%, p<0.01) and non-white (25.7%-vs-21.4%, p<0.01). MV 
CAD treated with staged PCI was not associated with increased in-hospital mortality in comparison to a broad group of CO PCI patients (by 
stepwise logistic regression analysis) [3.17%-vs-3.9%, adjusted odds ratio (OR) for in-hospital mortality 0.84, 95% CI 0.72-0.97, p=0.016]. 
Older age (OR 2.16, p=0.003), female sex (OR 4.0, p<0.001), diabetes mellitus (OR 1.64, p=0.013), peripheral vascular disease (OR 4.36, 
p<0.001), cardiogenic shock (OR 14.97, p<0.01), ventricular fibrillation (VF) (OR 7.27, p<0.001) and acute renal failure (OR 5.31, p<0.001) 
were found to be independent predictors of mortality in staged PCI treated MV CAD patients; while anterior STEMI (OR 1.25, p=0.44), 
history of hypertension (OR 0.89, p=0.396) and dyslipidemia (OR 0.77, p=0.159) were not. White race (OR 0.53, p=0.002), admission to 
a teaching hospital (OR 0.41, p<0.01) and smoking (OR 0.55, p=0.044) were independent negative predictors of mortality. Staged PCI did 
not result in increased retroperitoneal hemorrhage (OR 1.08, p=0.87).
conclusion:  Staged PCI was performed in only a small percentage of STEMI patients. Staged PCI was not associated with worse 
outcomes than CO- PCI.
